4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-15-070834
Vice President & CFO bought 10,000 shares at $0.78 ($7,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maimon Yossi Vice President & CFO | 2015-12-14 | Purchase | +10,000 | $0.78 | $7,800 | 10,000 | D |
| Open-market purchases · 10,000 sh · avg $0.78 · $7,800 | |||||||
Loading xslF345X03/v426950_4.xml…